Search alternatives:
point decrease » point increase (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
3 point » 3d point (Expand Search), 3 points (Expand Search), _ point (Expand Search)
point decrease » point increase (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
3 point » 3d point (Expand Search), 3 points (Expand Search), _ point (Expand Search)
-
105941
Table1_Tolerability, safety, and pharmacokinetics of a single intravenous administration of a novel recombinant humanized anti-interleukin-6 receptor monoclonal antibody in healthy...
Published 2024“…Samples for pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity were collected at specified time points and analyzed through validated methods. Adverse events and the results of the examination and laboratory were analyzed to assess the safety profile.…”
-
105942
DataSheet_1_Differential analysis of transcriptomic and metabolomic of free fatty acid rancidity process in oil palm (Elaeis guineensis) fruits of different husk types.doc
Published 2023“…FATB fluctuates unevenly in MT and MP, with the level of expression growing steadily in MT and decreasing in MP before increasing. The amount of SDR gene expression varies in opposite directions in both shell types. …”
-
105943
Mode of virus transmission differentially steers susceptibility to entry inhibition.
Published 2012“…Red and black values denote IC50 (nM) of during cell-cell and cell-free transmission, respectively. Data points represent means of duplicates from three independent inhibition experiments. …”
-
105944
Table_1_Association between dietary approaches to stop hypertension eating pattern and lung cancer risk in 98,459 participants: results from a large prospective study.docx
Published 2023“…The mean (standard deviation) DASH score was 24.00 (4.62) points, along with the mean follow-up period of 8.84 (1.94) years. …”
-
105945
Table_S2_Substance Use in Mild-COVID-19 Patients: A Retrospective Study.XLSX
Published 2021“…After this phase (median = 108 days after intake, IQR = 76–137), we asked these patients who were classified as experiencing mild COVID-19 (n = 993) about last-month substance use in three time-points: pre-COVID, just after COVID-19 acute phase (post-COVID acute phase) and in the period before survey (post-COVID follow-up phase).…”
-
105946
Table_2_Association between dietary approaches to stop hypertension eating pattern and lung cancer risk in 98,459 participants: results from a large prospective study.DOCX
Published 2023“…The mean (standard deviation) DASH score was 24.00 (4.62) points, along with the mean follow-up period of 8.84 (1.94) years. …”
-
105947
Table_S1_Substance Use in Mild-COVID-19 Patients: A Retrospective Study.XLSX
Published 2021“…After this phase (median = 108 days after intake, IQR = 76–137), we asked these patients who were classified as experiencing mild COVID-19 (n = 993) about last-month substance use in three time-points: pre-COVID, just after COVID-19 acute phase (post-COVID acute phase) and in the period before survey (post-COVID follow-up phase).…”
-
105948
Table_S2_Substance Use in Mild-COVID-19 Patients: A Retrospective Study.XLSX
Published 2021“…After this phase (median = 108 days after intake, IQR = 76–137), we asked these patients who were classified as experiencing mild COVID-19 (n = 993) about last-month substance use in three time-points: pre-COVID, just after COVID-19 acute phase (post-COVID acute phase) and in the period before survey (post-COVID follow-up phase).…”
-
105949
Table_S1_Substance Use in Mild-COVID-19 Patients: A Retrospective Study.XLSX
Published 2021“…After this phase (median = 108 days after intake, IQR = 76–137), we asked these patients who were classified as experiencing mild COVID-19 (n = 993) about last-month substance use in three time-points: pre-COVID, just after COVID-19 acute phase (post-COVID acute phase) and in the period before survey (post-COVID follow-up phase).…”
-
105950
Design of an inducible CRISPRi gene-silencing system for <i>S</i>. <i>mutans</i>.
Published 2020“…As the xylose concentration was decreased, data points change from a dark to a light blue color. …”
-
105951
Interaction between tombusvirus replication proteins and Pdc1 fermentation enzyme.
Published 2019“…Each experiment was repeated three times.</p>…”